project id: TCGA-HNSC; case submitter id: TCGA-CV-A45Z; source center: 23; state: released; a260 a280 ratio: 2.0; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 8.0; age at index: 75; days to birth: -27397; days to death: 1466; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1925; year of death: 2004; age at diagnosis: 27397; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage II; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic t: T1; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C32.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Larynx, NOS; synchronous malignancy: No; tissue or organ of origin: Larynx, NOS; tumor grade: Not Reported; year of diagnosis: 2000; treatment or therapy: no; alcohol history: Yes; cigarettes per day: 2.191780821917808; pack years smoked: 40.0; is ffpe: false; composition: Not Reported; days to collection: 4438; days to sample procurement: 0; initial weight: 160.0; portion submitter id: TCGA-CV-A45Z-01A-21; percent lymphocyte infiltration: 100.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 70.0;